Radiation therapy in prostate cancer
This article was originally published in Clinica
Treatment of early-stage prostate cancer with external beam radiation therapy (EBRT) carries a lower risk of subsequent impotency than nerve-sparing surgery, a new study shows. The findings, presented at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Florida this month, showed that EBRT for patients aged 50 to 69 years resulted in slightly lower impotency rates than nerve-sparing surgery in patients of the same age range.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.